Latest News for: therapeutic food

Edit

Hispanic UCF students feed their roots by learning their culture’s dishes

Orlando Sentinel 07 Nov 2021
Now, he considers cooking Cuban food therapeutic for when he ...
Edit

Understanding Naturopathic Medicine in the healthcare system

B & FT Online 06 Nov 2021
utilizes physiological, psychological and mechanical methods, such as air, water, light, heat, earth, phototherapy, food and herb therapy, psychotherapy, electrotherapy, physiotherapy, minor and orificial surgery, mechano-therapy, natural processed foods and herbs and nature’s remedies.
Edit

Ocugen, Inc. Announces Submission of Emergency Use Authorization Request to the US FDA for ...

The Baytown Sun 05 Nov 2021
OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of Ocugen’s COVID-19 ...
Edit

Tarsus Pharmaceuticals, Inc. Presents Data from Two Pioneering Studies on the Prevalence and ...

Kentucky New Era 04 Nov 2021
Food and Drug Administration (FDA) approved therapeutics for Demodex blepharitis ... About TP-03 TP-03 (lotilaner ophthalmic solution, 0.25%) is a novel, investigational therapeutic designed to resolve the signs of Demodex blepharitis by targeting and eradicating the root cause of the disease – Demodex mite infestation.
Edit

Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T™ ...

Kentucky New Era 04 Nov 2021
04, 2021 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc ... Food and Drug Administration (FDA) ... About Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer.
Edit

Mass General Brigham Joins Better Therapeutics in Real World Evidence Study Collaboration

The Marshall News Messenger 02 Nov 2021
Mass General Brigham will conduct an open-label, randomized, controlled study of approximately 750 patients with type 2 diabetes, extending Better Therapeutics’ ongoing effort to demonstrate real world effectiveness of the use of BT-001 ... Food & Drug Association (FDA) ... About Better Therapeutics ... Better Therapeutics, Inc.
Edit

GeneVentiv Receives Orphan Drug Designation (ODD) for GENV-HEM for the Treatment of Hemophilia A or ...

Watauga Democrat 02 Nov 2021
2, 2021 /PRNewswire/ -- GeneVentiv Therapeutics, a pre-clinical gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to GENV-HEM for the treatment of Hemophilia A or B with or without inhibitors ... About GeneVentiv Therapeutics. ... SOURCE GeneVentiv Therapeutics, Inc.
×